bempegaldesleukin (BEMPEG; NKTR-214)

bempegaldesleukin · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for bempegaldesleukin (BEMPEG; NKTR-214), covering 2023-03-24 to 2024-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 [Phase 1]

See pricing